|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Restricted Stock Units | $ 0 | 01/29/2015 | M | 12,150 | 01/29/2015(7) | (7) | Common Stock | 12,150 | $ 0 | 0 | D | ||||
Employee Stock Option - Right to Buy | $ 23.44 | 01/29/2015 | M | 7,300 | 01/29/2015 | 02/22/2022 | Common Stock | 7,300 | $ 0 | 7,398 | D | ||||
Employee Stock Option - Right to Buy | $ 30.9 | 01/29/2015 | M | 16,792 | 01/29/2015 | 03/06/2023 | Common Stock | 16,792 | $ 0 | 13,251 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Mauro Anthony 1000 MYLAN BLVD CANONSBURG, PA 15317 |
President, North America |
/s/ Bradley L. Wideman, by power of attorney | 02/02/2015 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Represents acquisition of shares of Mylan common stock upon vesting of RSUs. |
(2) | Represents acquisition of shares of Mylan common stock upon vesting of PRSUs. Each PRSU represents the right to receive shares of Mylan common stock. The PRSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014. |
(3) | Represents withholding of shares of Mylan common stock for the tax liability associated with the vesting of RSUs and PRSUs. |
(4) | Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012. |
(5) | Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013. |
(6) | Represents withholding of shares of Mylan common stock to satisfy the exercise price and tax liability associated with the exercise of stock options granted on February 22, 2012 and March 6, 2013. |
(7) | Each RSU represents the right to receive one share of Mylan common stock. The RSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014. |
Remarks: The transactions described on this Form 4 are described in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014. In connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, Mylan's Board of Directors determined, effective November 4, 2014, that the vesting of all unvested stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs") granted to directors and executive officers as part of Mylan's ordinary course annual equity compensation program (other than incentive stock options and the options granted in 2014) would be accelerated prior to the Transaction. |